Press/Media
- 100 - 125 out of 170 results
Search results
-
Monthly: Regeneron (REGN: $878.29) rises 9% on high volatility in December 2023
12/29/23
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $933.20) rises for a third consecutive week, a three-week rise of 10%; +$20.03 [2.2%]
1/13/24
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $933.20) rises for a third consecutive week, a three-week rise of 10%; +$20.03 [2.2%]
1/16/24
1 item of Media coverage
Press/Media: Research
-
Regeneron Shares Preliminary Results Showing Gene Therapy Improves Auditory Responses in Child with Profound Genetic Hearing Loss
10/31/23
1 item of Media coverage
Press/Media: Research
-
Monthly: Regeneron (REGN: $823.81) adds $5 billion in MCap in November, leads Medical/Biomedical sector gains
12/4/23
1 item of Media coverage
Press/Media: Research
-
General Characteristics of Protists that You Must Know, Here are 5 of them!
7/3/22
1 item of Media coverage
Press/Media: Research
-
Press Releases 65 Fellows Elected into the American Academy of Microbiology
2/24/21
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $859.14) keeps rising: up 7% in 4 weeks; +$19 [2.3%] Vol Index 1.3 [1 is avg]
12/16/23
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $913.17) lifts 4.0% - outperforming 83% of stocks; +$34.88 [4.0%]
1/8/24
1 item of Media coverage
Press/Media: Research
-
Overcoming Hearing Healthcare Barriers to Realize Gene Therapy Promise
2/7/24
1 item of Media coverage
Press/Media: Research
-
Monthly: Regeneron (REGN: $779.89) falls for a second consecutive month, a two-month fall of 6%
11/1/23
1 item of Media coverage
Press/Media: Research
-
Biomedical Engineering Award for the study of cochlear implants
4/16/21
1 item of Media coverage
Press/Media: Research
-
Some children born deaf in China finally able to hear after gene therapy, report says
11/1/23
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $840.14) accelerates rise: up 5% in 2 weeks; +$25.28 [3.1%]
12/11/23
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $802.43) in top 1% performers of NASDAQ-100 Index in past week; +$3.49 [0.4%]
11/18/23
1 item of Media coverage
Press/Media: Research
-
Weekly: Regeneron (REGN: $814.86) lifts 2.1% on average volume; +$16.56 [2.1%]
12/2/23
1 item of Media coverage
Press/Media: Research
-
First gene therapy trial to cure childhood deafness
10/18/23
1 item of Media coverage
Press/Media: Research
-
Regeneron Shares Preliminary Results Showing Gene Therapy Improves Auditory Responses in Child with Profound Genetic Hearing Loss
10/30/23
1 item of Media coverage
Press/Media: Research
-
Bonds Weekly: Regeneron Pharmaceuticals Inc bonds YTM decreases by 33 basis points
11/6/23
1 item of Media coverage
Press/Media: Research
-
ASM News American Academy of Microbiology Elects Class of 2021 Fellows
2/17/21
1 item of Media coverage
Press/Media: Research
-
What biologists call a species is becoming more than just a name
10/14/21
1 item of Media coverage
Press/Media: Research
-
MY01 Presents Clinical Trial Data At Orthopaedic Trauma Association Annual Meeting'
10/14/22
154 items of Media coverage
Press/Media: Research
-
65 FELLOWS ELECTED INTO THE AMERICAN ACADEMY OF MICROBIOLOGY
2/16/21
1 item of Media coverage
Press/Media: Research
-
New genetic testing clinic for children with hearing loss
1/25/23
1 item of Media coverage
Press/Media: Research
-
UK hospital launches world-first gene therapy trial to cure rare deafness
10/12/23
12 items of Media coverage
Press/Media: Research